female infertility. female infertility
Conditions
Interventions
Intervention 1: As control group, 30 patients randomly received routine flexible GNRH antagonist when the leading follicle diameter reached = 13 mm and HMG/rFSH is starting on cycle day 2 until approp
Treatment - Drugs
As control group, 30 patients randomly received routine flexible GNRH antagonist when the leading follicle diameter reached = 13 mm and HMG/rFSH is starting on cycle day 2 until appropriate dominant f
30 patients randomly received routine flexible GNRH antagonist when the leading follicle diameter reached = 13 mm and HMG/rFSH is starting on cycle day 2 until appropriate dominant follicles are reach
Sponsors
Yazd research and clinical center for infertility
Eligibility
Sex/Gender
Female
Age
20 Years to 39 Years
Inclusion criteria
Inclusion criteria: Inclusion criteria: FSH10, 20>age >39, endometriosis,infertility due to other than male or tubal factor, the patient with liver and kidney and heart disease.
Exclusion criteria
Exclusion criteria:
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| The number of oocyte retrival. Timepoint: the day of puncture. Method of measurement: counting by microscope. | — |
Secondary
| Measure | Time frame |
|---|---|
| Chemical pregnancy. Timepoint: 14 days after embryo transfer. Method of measurement: serum BHCG. | — |
Countries
Iran (Islamic Republic of)
Contacts
Public ContactDr.Elham Rahmani
Yazd research and clinical center for infertility
Outcome results
None listed